B25.0
Cytomegaloviral pneumonitis
Clinical Classification Guidelines
Medical Intelligence & Overview
Cytomegaloviral pneumonitis is an inflammation of the lungs caused by the cytomegalovirus (CMV). This condition predominantly affects individuals with weakened immune systems, such as those who have received organ transplants, are living with HIV/AIDS, or are undergoing chemotherapy. Recognizing the signs and understanding the causes can help manage the condition effectively under medical supervision.
Causes & Symptoms
Clinical Causes: Reactivation of dormant CMV in individuals with compromised immune systems Exposure to active CMV from close contact with infected persons Transmission through bodily fluids like blood, saliva, urine, or breast milk
Key Symptoms: Persistent cough Shortness of breath or difficulty breathing Chest pain or discomfort Fever or chills Fatigue or weakness Unintended weight loss Wheezing or crackling sounds in the lungs
Diagnostic & Treatment
Diagnosis Path: Diagnosis of cytomegaloviral pneumonitis involves a combination of clinical evaluation and specialized tests. Medical providers may employ:
Treatment Protocols: Managing cytomegaloviral pneumonitis primarily involves antiviral medications aimed at reducing viral activity. Treatment options may include:
Clinical Advice & FAQs
Billing Guidance
Is B25.0 a billable ICD-10 code?
Yes, B25.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B25.0?
Clinical documentation must specify the nature of Cytomegaloviral pneumonitis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference